SecBot SecBot
8-K ·Filed May 11, 2026

BRRN

Bryn Inc.
MIXED
Impact 6/10
Horizonweeks Processed5mo ago SEC0001213900-26-054461
8-K material event: Items 5.01
Actionable Insight ◆ Mixed

This change of control positions Bryn Inc. for a potential reverse merger or business injection. Monitor for subsequent 8-K filings regarding a business combination, capital raise, or asset acquisition. The new management's investment banking background (Primary Capital) suggests deal activity may be forthcoming.

DirectionMixed
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d
BRRN ▼ -58.28% at T+60d
NEUTRAL call -58.28% · α vs SPY -62.66% · entry $0.2900 → $0.1210
Entry = T+0 close
May 11, 2026
via day close
T+1d
0.00%
call 0.00% · α -0.54%
$0.2900
settled 6mo ago
T+5d
-10.34%
call -10.34% · α -10.42%
$0.2600
settled 5mo ago
T+20d
-37.93%
call -37.93% · α -36.20%
$0.1800
settled 5mo ago
T+60d
-58.28%
call -58.28% · α -62.66%
$0.1210
settled 3mo ago

Price Chart

Loading chart...

Executive Summary

MEDO Healthcare acquired 84.7% voting control of Bryn Inc. by purchasing 10 million Series A-1 Preferred shares for $175,000, triggering a change in control. Former sole director David Lazar resigned, and John Leo was appointed CEO and sole director, with Arthur Magee as CFO. The micro-cap shell company now has new management with investment banking backgrounds, setting the stage for a potential reverse merger or business combination.

Key Facts

  • MEDO Healthcare purchased 10M Series A-1 Preferred shares from Custodian Ventures for $175,000 cash, gaining 84.7% voting power (each preferred share = 250 common votes).
  • David Lazar resigned as sole director/officer; John Leo appointed CEO and sole director; Arthur Magee appointed CFO and Secretary.
  • John Leo holds a 27.4% membership interest in MEDO Healthcare and controls Primary Capital LLC.
  • Common stock outstanding: 450M shares; issued Series A-1 Preferred: 10M shares.
  • No financial statements or business plan disclosed in the filing.

Financial Impact

MEDO Healthcare paid $175,000 for voting control representing 84.7% of total voting power

voting controlownership structure

Risk Factors

  • Potential dilution from conversion of Series A-1 Preferred into common (10M preferred = 2.5B common if converted).
  • No current operating business or revenue – essentially a shell post-transaction.
  • Further dilutive offerings likely if the company raises capital for a transaction.

Market Snapshot

Exchange
OTC
Sector
Services-Management Services

Investment Themes

Services

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001213900-26-054461
Document: 0001213900-26-054461-index-headers.html0001213900-26-054461
Document: 0001213900-26-054461-index.html0001213900-26-054461
Document: 0001213900-26-054461.txt0001213900-26-054461

US Market Status

Market Closed — Opens in 6h 27m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 11, 2026